Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2008-02-25

Clinical Trial Update: China Cimicifuga Trial of Climacteric Complaint Control [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial in China is evaluating Cimicifuga (black cohosh) for climacteric symptoms; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Black Cohosh (Actaea racemosa)

Snippet

Sponsor: Shandong Luye Pharmaceutical Co., Ltd. | Conditions: Climacteric Symptoms | Phase 4 | Status: UNKNOWN